| Financial Year |
March 31 2023 |
| Monetary Funds |
1,101,173,619.52 |
| Held-for-trading Financial Assets |
156,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
256,020,470.88 |
| Advances to Suppliers |
349,250,108.24 |
| Other Receivables |
25,513,417.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,306,034,897.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
192,766,501.03 |
| Total Current Assets |
3,397,996,425.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,452,153,046.57 |
| Investment Properties |
-- |
| Fixed Assetes |
949,559,312.20 |
| Under-construction Projects |
265,627,762.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
6,326.39 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
217,708,369.15 |
| R&D expenses |
-- |
| Goodwill |
18,622,541.67 |
| Long-Term Deferred and Prepaid Expenses |
2,441,495.69 |
| Deferred Income Tax Assets |
4,785,146.59 |
| Other Non-Current Assets |
17,713,194.13 |
| Sub-Total of Non-Current Assets |
3,027,395,927.55 |
| Total Assets |
6,425,392,353.47 |
| Short-Term Loans |
1,748,871,413.80 |
| Trading Financial liabilities |
1,651,729.16 |
| Notes Payable |
26,600,000.00 |
| Accounts Payable |
162,228,252.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,955,090.80 |
| Taxes Payable |
25,630,918.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
244,905,497.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
368,714.10 |
| Other Current Liabilities |
16,317,332.40 |
| Sub-Total of Current Liabilities |
2,500,853,256.97 |
| Long-term Loans |
202,726,249.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,291,652.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
256,006,879.68 |
| Total Liabilities |
2,756,860,136.65 |
| Paid-In Capital(Or Share Stock) |
779,001,783.00 |
| Capital Surplus |
388,439,366.15 |
| Surplus Reserve |
268,666,859.22 |
| LESS:Treasury Stock |
5,886,168.00 |
| Undistributed Profits |
2,037,797,511.75 |
| Minority Stockholder's Interest |
197,077,927.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,471,454,289.43 |
| Owner's Equity（Stockholder's Equity） |
3,668,532,216.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,425,392,353.47 |
